| Line Item | 2026-01-25 | Y/Y |
|---|---|---|
| Revenue | $215.94B | +65.5% |
| Cost of Revenue | $62.48B | +91.4% |
| Gross Profit | $153.46B | +56.8% |
| R&D Expense | $18.50B | +43.2% |
| SG&A Expense | $4.58B | +31.2% |
| Operating Income | $130.39B | +60.1% |
| Pre-tax Income | $141.45B | +68.3% |
| Income Tax | $21.38B | +91.8% |
| Net Income | $120.07B |
| Line Item | 2026-01-25 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.61B | +23.5% |
| Accounts Receivable | $38.47B | +66.8% |
| Inventory | $21.40B | +112.3% |
| Current Assets | $125.61B | +56.8% |
| Total Assets | $206.80B | +85.3% |
| Current Liabilities | $32.16B | +78.2% |
| Long-term Debt | $8.47B | +0.1% |
| Line Item | 2026-01-25 | Y/Y |
|---|---|---|
| Operating Cash Flow | $102.72B | +60.3% |
| Investing Cash Flow | -$52.23B | -155.8% |
| Financing Cash Flow | -$48.47B | -14.4% |
| +64.7% |
| EPS (Basic) | $4.93 | +66.0% |
| EPS (Diluted) | $4.90 | +66.7% |
| Total Liabilities |
| $49.51B |
| +53.4% |
| Stockholders' Equity | $157.29B | +98.3% |